Socioeconomic inequality in cancer in the Nordic countries. A systematic review

Research output: Contribution to journalReviewResearchpeer-review

Standard

Socioeconomic inequality in cancer in the Nordic countries. A systematic review. / Ammitzbøll, Gunn; Levinsen, Anne Katrine Graudal; Kjær, Trille Kristina; Ebbestad, Freja Ejlebæk; Horsbøl, Trine Allerslev; Saltbæk, Lena; Badre-Esfahani, Sara Koed; Joensen, Andrea; Kjeldsted, Eva; Halgren Olsen, Maja; Dalton, Susanne Oksbjerg.

In: Acta Oncologica, Vol. 61, No. 11, 2022, p. 1317-1331.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Ammitzbøll, G, Levinsen, AKG, Kjær, TK, Ebbestad, FE, Horsbøl, TA, Saltbæk, L, Badre-Esfahani, SK, Joensen, A, Kjeldsted, E, Halgren Olsen, M & Dalton, SO 2022, 'Socioeconomic inequality in cancer in the Nordic countries. A systematic review', Acta Oncologica, vol. 61, no. 11, pp. 1317-1331. https://doi.org/10.1080/0284186X.2022.2143278

APA

Ammitzbøll, G., Levinsen, A. K. G., Kjær, T. K., Ebbestad, F. E., Horsbøl, T. A., Saltbæk, L., Badre-Esfahani, S. K., Joensen, A., Kjeldsted, E., Halgren Olsen, M., & Dalton, S. O. (2022). Socioeconomic inequality in cancer in the Nordic countries. A systematic review. Acta Oncologica, 61(11), 1317-1331. https://doi.org/10.1080/0284186X.2022.2143278

Vancouver

Ammitzbøll G, Levinsen AKG, Kjær TK, Ebbestad FE, Horsbøl TA, Saltbæk L et al. Socioeconomic inequality in cancer in the Nordic countries. A systematic review. Acta Oncologica. 2022;61(11):1317-1331. https://doi.org/10.1080/0284186X.2022.2143278

Author

Ammitzbøll, Gunn ; Levinsen, Anne Katrine Graudal ; Kjær, Trille Kristina ; Ebbestad, Freja Ejlebæk ; Horsbøl, Trine Allerslev ; Saltbæk, Lena ; Badre-Esfahani, Sara Koed ; Joensen, Andrea ; Kjeldsted, Eva ; Halgren Olsen, Maja ; Dalton, Susanne Oksbjerg. / Socioeconomic inequality in cancer in the Nordic countries. A systematic review. In: Acta Oncologica. 2022 ; Vol. 61, No. 11. pp. 1317-1331.

Bibtex

@article{608f4e1b0f2142959d7b4aec6faea4cd,
title = "Socioeconomic inequality in cancer in the Nordic countries. A systematic review",
abstract = "Background: Despite structural and cultural similarities across the Nordic countries, differences in cancer survival remain. With a focus on similarities and differences between the Nordic countries, we investigated the association between socioeconomic position (SEP) and stage at diagnosis, anticancer treatment and cancer survival to describe patterns, explore underlying mechanisms and identify knowledge gaps in the Nordic countries Methods: We conducted a systematic review of population based observational studies. A systematic search in PubMed, EMBASE and Medline up till May 2021 was performed, and titles, abstracts and full texts were screened for eligibility by two investigators independently. We extracted estimates of the association between SEP defined as education or income and cancer stage at diagnosis, received anticancer treatment or survival for adult patients with cancer in the Nordic countries. Further, we extracted information on study characteristics, confounding variables, cancer type and results in the available measurements with corresponding confidence intervals (CI) and/or p-values. Results were synthesized in forest plots. Results: From the systematic literature search, we retrieved 3629 studies, which were screened for eligibility, and could include 98 studies for data extraction. Results showed a clear pattern across the Nordic countries of socioeconomic inequality in terms of advanced stage at diagnosis, less favorable treatment and lower cause-specific and overall survival among people with lower SEP, regardless of whether SEP was measured as education or income. Conclusion: Despite gaps in the literature, the consistency in results across cancer types, countries and cancer outcomes shows a clear pattern of systematic socioeconomic inequality in cancer stage, treatment and survival in the Nordic countries. Stage and anticancer treatment explain some, but not all of the observed inequality in overall and cause-specific survival. The need for further studies describing this association may therefore be limited, warranting next step research into interventions to reduce inequality in cancer outcomes. Study registration: Prospero protocol no: CRD42020166296.",
keywords = "Cancer, diagnosis, socioeconomic, survival, treatment",
author = "Gunn Ammitzb{\o}ll and Levinsen, {Anne Katrine Graudal} and Kj{\ae}r, {Trille Kristina} and Ebbestad, {Freja Ejleb{\ae}k} and Horsb{\o}l, {Trine Allerslev} and Lena Saltb{\ae}k and Badre-Esfahani, {Sara Koed} and Andrea Joensen and Eva Kjeldsted and {Halgren Olsen}, Maja and Dalton, {Susanne Oksbjerg}",
note = "Publisher Copyright: {\textcopyright} 2022 Acta Oncologica Foundation.",
year = "2022",
doi = "10.1080/0284186X.2022.2143278",
language = "English",
volume = "61",
pages = "1317--1331",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "11",

}

RIS

TY - JOUR

T1 - Socioeconomic inequality in cancer in the Nordic countries. A systematic review

AU - Ammitzbøll, Gunn

AU - Levinsen, Anne Katrine Graudal

AU - Kjær, Trille Kristina

AU - Ebbestad, Freja Ejlebæk

AU - Horsbøl, Trine Allerslev

AU - Saltbæk, Lena

AU - Badre-Esfahani, Sara Koed

AU - Joensen, Andrea

AU - Kjeldsted, Eva

AU - Halgren Olsen, Maja

AU - Dalton, Susanne Oksbjerg

N1 - Publisher Copyright: © 2022 Acta Oncologica Foundation.

PY - 2022

Y1 - 2022

N2 - Background: Despite structural and cultural similarities across the Nordic countries, differences in cancer survival remain. With a focus on similarities and differences between the Nordic countries, we investigated the association between socioeconomic position (SEP) and stage at diagnosis, anticancer treatment and cancer survival to describe patterns, explore underlying mechanisms and identify knowledge gaps in the Nordic countries Methods: We conducted a systematic review of population based observational studies. A systematic search in PubMed, EMBASE and Medline up till May 2021 was performed, and titles, abstracts and full texts were screened for eligibility by two investigators independently. We extracted estimates of the association between SEP defined as education or income and cancer stage at diagnosis, received anticancer treatment or survival for adult patients with cancer in the Nordic countries. Further, we extracted information on study characteristics, confounding variables, cancer type and results in the available measurements with corresponding confidence intervals (CI) and/or p-values. Results were synthesized in forest plots. Results: From the systematic literature search, we retrieved 3629 studies, which were screened for eligibility, and could include 98 studies for data extraction. Results showed a clear pattern across the Nordic countries of socioeconomic inequality in terms of advanced stage at diagnosis, less favorable treatment and lower cause-specific and overall survival among people with lower SEP, regardless of whether SEP was measured as education or income. Conclusion: Despite gaps in the literature, the consistency in results across cancer types, countries and cancer outcomes shows a clear pattern of systematic socioeconomic inequality in cancer stage, treatment and survival in the Nordic countries. Stage and anticancer treatment explain some, but not all of the observed inequality in overall and cause-specific survival. The need for further studies describing this association may therefore be limited, warranting next step research into interventions to reduce inequality in cancer outcomes. Study registration: Prospero protocol no: CRD42020166296.

AB - Background: Despite structural and cultural similarities across the Nordic countries, differences in cancer survival remain. With a focus on similarities and differences between the Nordic countries, we investigated the association between socioeconomic position (SEP) and stage at diagnosis, anticancer treatment and cancer survival to describe patterns, explore underlying mechanisms and identify knowledge gaps in the Nordic countries Methods: We conducted a systematic review of population based observational studies. A systematic search in PubMed, EMBASE and Medline up till May 2021 was performed, and titles, abstracts and full texts were screened for eligibility by two investigators independently. We extracted estimates of the association between SEP defined as education or income and cancer stage at diagnosis, received anticancer treatment or survival for adult patients with cancer in the Nordic countries. Further, we extracted information on study characteristics, confounding variables, cancer type and results in the available measurements with corresponding confidence intervals (CI) and/or p-values. Results were synthesized in forest plots. Results: From the systematic literature search, we retrieved 3629 studies, which were screened for eligibility, and could include 98 studies for data extraction. Results showed a clear pattern across the Nordic countries of socioeconomic inequality in terms of advanced stage at diagnosis, less favorable treatment and lower cause-specific and overall survival among people with lower SEP, regardless of whether SEP was measured as education or income. Conclusion: Despite gaps in the literature, the consistency in results across cancer types, countries and cancer outcomes shows a clear pattern of systematic socioeconomic inequality in cancer stage, treatment and survival in the Nordic countries. Stage and anticancer treatment explain some, but not all of the observed inequality in overall and cause-specific survival. The need for further studies describing this association may therefore be limited, warranting next step research into interventions to reduce inequality in cancer outcomes. Study registration: Prospero protocol no: CRD42020166296.

KW - Cancer

KW - diagnosis

KW - socioeconomic

KW - survival

KW - treatment

U2 - 10.1080/0284186X.2022.2143278

DO - 10.1080/0284186X.2022.2143278

M3 - Review

C2 - 36369792

AN - SCOPUS:85142179393

VL - 61

SP - 1317

EP - 1331

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 11

ER -

ID: 340537832